AllianceBernstein’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$158K Hold
64,550
﹤0.01% 3097
2025
Q4
$158K Hold
64,550
﹤0.01% 3107
2025
Q3
$433K Hold
64,550
﹤0.01% 2754
2025
Q2
$380K Buy
64,550
+6,400
+11% +$41.7K ﹤0.01% 2801
2025
Q1
$488K Sell
58,150
-8,030
-12% -$72.2K ﹤0.01% 2561
2024
Q4
$492K Sell
66,180
-8,950
-12% -$59.9K ﹤0.01% 2645
2024
Q3
$436K Hold
75,130
﹤0.01% 2734
2024
Q2
$500K Buy
75,130
+13,000
+21% +$105K ﹤0.01% 2668
2024
Q1
$811K Hold
62,130
﹤0.01% 2377
2023
Q4
$792K Sell
62,130
-4,246,712
-99% -$42.9M ﹤0.01% 2386
2023
Q3
$56.5M Buy
4,308,842
+884,611
+26% +$16.2M 0.02% 525
2023
Q2
$87.6M Buy
3,424,231
+206,511
+6% +$5.33M 0.04% 430
2023
Q1
$81.1M Buy
3,217,720
+21,298
+0.7% +$500K 0.03% 437
2022
Q4
$73.5M Sell
3,196,422
-60,924
-2% -$1.4M 0.03% 469
2022
Q3
$71.9M Sell
3,257,346
-47,596
-1% -$921K 0.03% 447
2022
Q2
$47.4M Buy
3,304,942
+146,297
+5% +$2.46M 0.02% 569
2022
Q1
$59.7M Buy
3,158,645
+703,752
+29% +$13.7M 0.02% 551
2021
Q4
$45.8M Buy
2,454,893
+597,376
+32% +$12.3M 0.02% 651
2021
Q3
$50M Buy
1,857,517
+84,728
+5% +$2.33M 0.02% 618
2021
Q2
$55.4M Buy
+1,772,789
New +$56.4M 0.02% 584

Other funds holding TMCI

AllianceBernstein's TMCI Position: Q1 2026 in Review

AllianceBernstein held its Treace Medical Concepts (TMCI) position steady in Q1 2026 at 64,550 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #3097.

AllianceBernstein first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $87.6M in Q2 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • AllianceBernstein held 64,550 shares of Treace Medical Concepts worth $158K as of Q1 2026.
  • AllianceBernstein left its Treace Medical Concepts share count unchanged in Q1 2026.
  • Treace Medical Concepts made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3097 holding.
  • AllianceBernstein first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
  • AllianceBernstein's Treace Medical Concepts position peaked at $87.6M in Q2 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.